Pharmacokinetics of pergolide after intravenous administration to horses

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Objective: To determine the pharmacokinetics of pergolide after IV administration to horses. Animals: 8 healthy adult horses. Procedures: Pergolide mesylate was administered IV at a dose of 20 µg/kg (equivalent to 15.2 µg of pergolide/kg) to each horse, and blood samples were collected over 48 hours. Pergolide concentrations in plasma were determined by means of high-performance liquid chromatography'tandem mass spectrometry, and pharmacokinetic parameters were determined on the basis of noncompartmental methods. Results: After IV administration of pergolide, mean ± SD clearance, elimination halflife, and initial volume of distribution were 959 ± 492 mL/h/kg, 5.64 ± 2.36 hours, and 0.79 ± 0.32 L/kg, respectively. Conclusions and clinical relevance: With an elimination half-life of approximately 6 hours, twice-daily dosing may be more appropriate than once-daily dosing to reduce peak-trough fluctuation in pergolide concentrations. Further pharmacodynamic and pharmacokinetic studies of pergolide and its metabolites will be necessary to determine plasma concentrations that correlate with clinical effectiveness to determine the therapeutic range for the treatment of pituitary pars intermedia dysfunction.
Original languageEnglish
Pages (from-to)155-160
Number of pages6
JournalAmerican Journal of Veterinary Research
Issue number2
Publication statusPublished - Feb 2015

Fingerprint Dive into the research topics of 'Pharmacokinetics of pergolide after intravenous administration to horses'. Together they form a unique fingerprint.

Cite this